An inherited mutation associated with functional deficiency of the α- subunit of the guanine nucleotide-binding protein G(s) in pseudo- and pseudopseudohypoparathyroidism

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 3, 1998, Pages 935-938

  Fischer, J A ^a,b   Egert, F ^a   Werder, E ^a   Born, W ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b BALGRIST UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; PARATHYROID HORMONE; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN; THYROTROPIN;

ALBRIGHT SYNDROME; ARTICLE; CLINICAL ARTICLE; EXON; FEMALE; GENE DELETION; GENE MUTATION; HUMAN; INTRON; MALE; PRIORITY JOURNAL; PSEUDOHYPOPARATHYROIDISM; PSEUDOPSEUDOHYPOPARATHYROIDISM;

ADOLESCENT; ADULT; ALLELES; BASE SEQUENCE; CHILD; CHILD, PRESCHOOL; FEMALE; GENE DELETION; GTP-BINDING PROTEINS; HUMANS; INFANT; MALE; MIDDLE AGED; MUTATION; PEDIGREE; POLYMERASE CHAIN REACTION; PSEUDOHYPOPARATHYROIDISM; PSEUDOPSEUDOHYPOPARATHYROIDISM; THYROTROPIN; THYROTROPIN-RELEASING HORMONE;

EID: 0031764968     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.83.3.935     Document Type: Article

References (23)

1. Albright F, Burnett CH, Smith PH, Parson W. 1942 Pseudohypoparathyroidism-an example of "Seabright-Bantam syndrome." Endocrinology. 30:922-932.
2. Nagant de Deuxchaisnes C, Fischer JA, Dambacher MA, et al. 1981 Dissociation of parathyroid hormone bioactivity and immunoreactivity in pseudohypoparathyroidism type I. J Clin Endocrinol Metab. 53:1105-1109.
3. Werder E, Illig R, Bernasconi S, et al. 1975 Excessive thyrotropin response to thyrotropin-releasing hormone in pseudohypoparathyroidism. Pediatr Res. 9:12-16.
4. Chase LR, Melson GL, Aurbach GD. 1969 Pseudohypoparyathyroidism: defective excretion of 3′,5′-AMP in response to parathyroid hormone. J Clin Invest. 48:1832-1844.
5. Werder EA, Fischer JA, Illig R, et al. 1978 Pseudohypoparathyroidism and idiopathic hypoparathyroidism: relationship between serum calcium and parathyroid hormone levels and urinary cyclic adenosine-3′,5′-monophosphate response to parathyroid extract. J Clin Endocrinol Metab. 46:872-879.
6. Farfel Z, Brickman AS, Kaslow HR, Brothers VM, Boume HR. 1980 Defect of receptor-cyclase coupling protein in pseudohypoparathyroidism. N Engl J Med. 393:237-242.
7. Levine MA, Downs Jr RW, Singer M, Marx SJ, Aurbach GD, Spiegel AM. 1980 Deficient activity of guanine nucleotide regulatory protein in erythrocytes from patients with pseudohypoparathyroidism. Biochem Biophys Res Commun. 94:1319-1324.
8. Fischer FA, Boume HR, Dambacher MA, et al. 1983 Pseudohypoparathyroidism: inheritance and expression of deficient receptor-cyclase coupling protein activity. Clin Endocrinol (Oxf). 19:747-754.
9. Levine MA, Jap T-S, Mauseth RS, Downs RW, Spiegel AM. 1986 Activity of the stimulatory guanine nucleotide-binding protein is reduced in erythrocytes from patients with pseudohypoparathyroidism and pseudopseudohypoparathyroidism: biochemical, endocrine, and genetic analysis of Albright's hereditary osteodystrophy in six kindreds. J Clin Endocrinol Metab. 62:497-502.
10. Saito T, Akita Y, Fujita H, et al. 1986 Stimulatory guanine nucleotide binding protein acitivity in the erythrocyte membrane of patients with pseudohypoparathyroidism type I and related disorders. Acta Endocrinol (Copenh). 111:507-515.
11. s as the molecular basis for Albright hereditary osteodystrophy. Proc Natl Acad Sci USA. 85:617-621.
12. Patten JL, Johns DR, Valle D, et al. 1990 Mutation in the gene encoding the stimulatory G protein of adenylate cyclase in Albright's hereditary osteodystrophy. N Engl J Med. 322:1412-1419.
13. s α-subunit gene in Albright heredidatry osteodystrophy detected by denaturing gradient gel electrophoresis. Proc Natl Acad Sci USA. 87:8287-8290.
14. sα impairs receptor stimulation. J Biol Chem. 271:19653-19655.
15. Scr mutant. Proc Natl Acad Sci USA. 94:5656-5661.
16. Levine MA. 1996 Pseudohypoparathyroidism. In: Bilezikian JP, Raisz LG, Rodan GA, eds. Principles of bone biology. San Diego: Academic Press; 853-876.
17. Loveridge N, Tschopp F, Born W, Devogelaer J-P, Nagant de Deuxchaisnes C, Fischer JA. 1986 Separation of inhibitory activity from biologically active parathyroid hormone in patients with pseuduhypoparathyroidism type I. Biochim Biophys Acta. 889:117-122.
18. Suarez F, Lebrun JJ, Lecossier D, Escoubet B, Coureau C, Silve C. 1995 Expression and modulation of the parathyroid hormone (PTH)/PTH-related peptide receptor messenger ribonucleic acid in skin fibroblasts from patients with type Ib pseudohypoparathyroidism.J Clin Endocrinol Metab. 80:965-970.
19. Schipani E, Weinstein LS, Bergwitz C, et al. 1995 Pseudohypoparathyroidism type Ib is not caused by mutations in the coding exons of the human parathyroid hormone (PTH)/PTH-related peptide receptor gene. J Clin Endocrinol Metab. 80:1611-1621.
20. Fukumoto S, Suzawa M, Takeuchi Y, et al. 1996 Absence of mutations in parathyroid hormone (PTH)/PTH-related protein receptor complementary deoxyribonucleic acid in patients with pseudohypoparathyroidism type Ib. J Clin Endocrinol Metab. 81:2554-2558.
21. Schwindinger WF, Reese KJ, Lawler AM, Gearhart JD, Levine MA. 1997 Targeted disruption of G-nas in embryonic stem cells. Endocrinology. 138:4058-4063.
22. Loveridge N, Fischer JA, Nagant de Deuxchaisnes C, et al. 1982 Inhibition of cytochemical bioactivity of parathyroid hormone by plasma in pseudohypoparathyroidism type I. J Clin Endocrinol Metab. 54:1274-1275.
23. Kolb FO, Steinbach HL. 1962 Pseudohypoparathyroidism with secondary hyperparathyroidism and osteitis fibrosa. J Clin Endocrinol Metab. 22:59-64.